ADENOSCAN Solution for infusion Ref.[27893] Active ingredients: Adenine Deoxy Nucleoside

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK

Product name and form

Adenoscan 30 mg/10 ml solution for infusion.

Pharmaceutical Form

Solution for infusion.

Adenoscan is a sterile clear, colourless solution.

Qualitative and quantitative composition

Each 10 ml vial of Adenoscan contains 30 mg of adenosine (3 mg/ml).

Excipient with known effect:

Each vial contains 1.54 mmol of sodium, which is 35.4 mg sodium.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Adenine Deoxy Nucleoside

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node.

List of Excipients

Sodium chloride
Water for injection

Pack sizes and marketing

Type I glass vials with chlorobutyl rubber stoppers, packs with 6 vials.

Marketing authorization holder

Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK

Trading as:

Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK

Marketing authorization dates and numbers

PL 04425/0682

Date of first authorisation: 03 May 1995
Date of latest renewal: 03 May 2010

Drugs

Drug Countries
ADENOSCAN Spain, France, Hong Kong, Japan, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.